-
2024 Tsinghua ASP Comes to a Successful Conclusion
From June 7th to August 3rd, 2024, 10 Tsinghua University “Amgen Scholars” from top universities in Asia completed their eight-week summer research training within the Tsinghua campus. This year’s Amgen Scholars Program, for the first time, collaborated with the Summer International School, allowing young talents from around the world to exchange ideas and share wisdom on the same platform.P... -
Program Rivew | 2023 ASP Brought to A Successful Close
From June 27th to August 19th, 2023, 24 top students from leading global universities participated in the Tsinghua University "Amgen Scholars" program on the Tsinghua campus, completing their 8-week summer research training.Tsinghua University, as a world-renowned institution, possesses international-level academic excellence in the field of biomedical research. In 2018, Tsinghua succes...
-
Professor Zhang Yonghui from the School of Pharmaceutical Sciences and his collaborators published a paper in Cell to propose a strategy for oral drug development targeting integrins
Latest Research ExpressOn September 15, 2022, the Harvard Medical School and the School of Pharmaceutical Sciences of Tsinghua University jointly published a research article entitled “A general chemical principle for creating closure-stabilizing integrin inhibitors” in Cell, introducing the challenges in the research and development of small molecule drugs targeting integrins, and proposing ... -
Ding Sheng and his team from the School of Pharmaceutical Sciences published groundbreaking research findings on totipotent stem cells in Nature
Professor Ding Sheng and his team from the School of Pharmaceutical Sciences have discovered for the first time a drug combination for in vitro directed induction and stable culturing of totipotent stem cells. The breakthrough research findings were published online by Nature on June 21, 2022 (Beijing Time). The research marks the opening of a whole new field of life creation research.1. Revolu...
